Publication Name	World Journal of Clinical Cases
Manuscript ID	84458
Country	Italy

Received	2023-03-14 22:55
Peer-Review Started	2023-03-14 22:57
To Make the First Decision
Return for Revision	2023-04-11 01:39
Revised	2023-05-04 07:44
Second Decision	2023-05-24 02:47
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-05-24 07:49
Articles in Press	2023-05-24 07:49
Publication Fee Transferred
Edit the Manuscript by Language Editor	2023-05-23 01:13
Typeset the Manuscript	2023-06-01 08:04
Publish the Manuscript Online	2023-09-08 09:38

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Dermatology
Manuscript Type	Case Report
Article Title	Mepolizumab induced palmoplantar psoriasis: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Fabio Artosi, Laura Diluvio, Martina Vultaggio, Elena Campione and Luca Bianchi
ORCID	Author(s) ORCID Number Fabio Artosi http://orcid.org/0000-0002-7636-3532
Funding Agency and Grant Number
Corresponding Author	Fabio Artosi, MD, Academic Fellow, Doctor, Department of Systems Medicine, University of Rome “Tor Vergata”, 81 Viale Oxford, Rome 00133, Italy. fabio.artosi994@gmail.com
Key Words	Psoriasis; Interleukin-5; Mepolizumab; Asthma; Immunology; Case report
Core Tip	We report the case of a 59-year-old patient with severe asthma who developed palmar psoriasis after 6 mo from the initiation of treatment with a humanized monoclonal antibody directed against interleukin-5 (IL-5), mepolizumab. There are several case reports of psoriasis induced by dupilumab therapy in the literature, but this phenomenon has not yet been recognized with modulating IL-5R signalling. This article reports the pathogenetic hypotheses that may underlie this phenomenon.
Publish Date	2023-09-08 09:38
Citation	Artosi F, Diluvio L, Vultaggio M, Campione E, Bianchi L. Mepolizumab induced palmoplantar psoriasis: A case report. World J Clin Cases 2023; 11(26): 6154-6158
URL	https://www.wjgnet.com/2307-8960/full/v11/i26/6154.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i26.6154

Full Article (PDF)	WJCC-11-6154-with-cover.pdf
Full Article (Word)	WJCC-11-6154.docx
Manuscript File	84458_Auto_Edited-YLC-Wang TQ-JLW.docx
Answering Reviewers	84458-Answering reviewers.pdf
Audio Core Tip	84458-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	84458-Conflict-of-interest statement.pdf
Copyright License Agreement	84458-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	84458-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	84458-Language certificate.pdf
Peer-review Report	84458-Peer-review(s).pdf
Scientific Misconduct Check	84458-Bing-Chen YL-2.png
Scientific Editor Work List	84458-Scientific editor work list.pdf